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The authors have derived a new ¯-cell line
(¯Ins2¡=¡lacZ)f r o mIns2¡=¡ mice that carry the lacZ
reporter gene under control of the Ins2 promoter.
¯Ins2¡=¡lacZ cells stained positively using anti-insulin
antibody, expressed ¯-cell–speciﬁc genes encoding the
transcription factor PDX-1, glucokinase, and Glut-2, re-
tainedglucose-responsivenessforinsulinsecretion,andex-
pressed the lacZ gene. Analysis of Ins1 expression by re-
verse transcriptase–polymerase chain reaction (RT-PCR)
showed that Ins1 transcripts were signiﬁcantly raised to
compensateforthelackofIns2transcriptsin¯Ins2¡=¡lacZ
cells, as compared to those found in¯TC1 cells expressing
both Ins1/Ins2. Thus, transcriptional up-regulation of the
remaining functional insulin gene in Ins2¡=¡ mice could
potentiallycontributetothe¯-celladaptationexhibitedby
these mutants, in addition to the increase in ¯-cell mass
thatwepreviouslyreported.WehavealsoshownthatlacZ
expression, as analyzed by determining ¯-galactosidase
activity,wasup-regulatedbyincubating¯Ins2¡=¡lacZcells
with GLP-1 and/or IBMX, 2 known stimulators of insulin
gene expression. These cells thus represent a new tool for
testing of molecules capable of stimulating Ins2 promoter
activity.
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Insulinresistanceand¯-celldysfunctionarethetwomajor
characteristicfeaturesoftype2diabetes.Itisnowwelladmit-
ted that overt diabetes does not develop as long as the ¯-cells
can secrete increasing amounts of insulin to overcome insulin
resistance [1]. Several groups have extensively investigated
the molecular mechanisms that regulate insulin gene expres-
sion as well as insulin secretion during the past several years
[2, 3]. Besides, a few studies in rodents also showed that the
¯-cell mass could signiﬁcantly increase during pregnancy [4]
or after glucose infusion for a short period, revealing poten-
tial plasticity of the ¯-cell compartment [5, 6]. Moreover, the
study of knockout mice for insulin receptor substrate (IRS)-1,
an intracellular mediator of insulin signaling, provided con-
vincing evidence that insulin resistance could be overcome if
¯-cell mass were increased [7]. This conclusion was strongly
supported by the observation that insulin resistance in IRS-2–
knockout mice, which fail to increase their ¯-cell mass, leads
to overt diabetes [8].
In recent years, transgenic and gene-targeting approaches
in the mouse were extensively applied to examine the effects
of manipulating the expression of genes encoding key players
in ¯-cell development and/or function, such as the transcrip-
tion factor PDX-1 [9, 10] or proteins involved in glucose-
regulated insulin secretion, such as glucokinase (GK) [11]
or the glucose transporter Glut-2 [12]. We previously gen-
erated knockout mice for the Ins1 and Ins2 genes [13]. The
single Ins1¡=¡ or Ins2¡=¡ mutants were viable, fertile, and
did not show any major metabolic alteration. Total pancreatic
insulin content in Ins1¡=¡ or Ins2¡=¡ mice was comparable
to that found in control animals, indicating that compensatory
up-regulations take place in these mutants. Analysis of the
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transcriptsoftheremainingfunctionalinsulingenerevealeda
dramatic increase of Ins1 transcripts in total pancreatic RNA
from Ins2¡=¡ mice. Interestingly, morphometric analysis of
the pancreases showed that ¯-cell mass in both kinds of mu-
tantswassigniﬁcantlyaugmented,particularlyinIns2¡=¡ mu-
tants. Thus, absence of either one of the 2 insulin genes was
partly compensated at the tissue level by a speciﬁc increase
of the ¯-cell compartment [13].
It was, however, difﬁcult to determine whether some com-
pensatory up-regulation of Ins1 could also take place in indi-
vidual ¯-cells in Ins2¡=¡ mice. We have addressed this issue
here using a ¯-cell line derived from Ins2¡=¡ mutants. Be-
causeIns2¡=¡ micecarrylacZreportergeneunderthecontrol
of the Ins2 promoter, such ¯-cells also represent an interest-
ing tool for the testing of drugs that could up-regulate Ins2
promoter activity.
MATERIALS AND METHODS
Animals
Generation of Ins2¡=¡ mice has been described previ-
ously [14]. These mutant mice were crossed with Rip1-Tag2
mice [15] (kindly provided by D. Hanahan) and an Ins2¡=¡,
Rip1-Tag2 mouse line was established. The offspring were
genotypedbypolymerasechainreaction(PCR)usingspeciﬁc
primers.
Derivation of the ¯Ins2¡=¡lacZ Cell Line
¯-Cell lines from Ins2¡=¡, Rip1-Tag2 mice were isolated
as previously described [16]. Brieﬂy, 10-week-old Ins2¡=¡,
Rip1-Tag2 mice were killed by cervical dislocation, and
the pancreases were perfused through the bile duct with
2 mg/mL collagenase (Sigma, St. Louis, MO) dissolved
in Hank’s buffered saline solution (HBSS; Life Technolo-
gies, Gaithersburg, MD). The pancreases were incubated
for 20 minutes at 37±C with gentle agitation. The digested
material was washed 3 times in HBSS containing 10% fe-
tal bovine serum (FBS; Techgen, Les Ullis, France) and
then recovered in RPMI with 10% FBS. Islets were hand-
picked under a dark-ﬁeld microscope and cultured in the
same medium in an incubator with 5% CO2 at 37±C. Islets
were then placed individually in 24-well plates and cultured
inhigh-glucosemediumcontaining25mMHepes(LifeTech-
nologies), 15% horse serum (Life Technologies), 2.5% FBS,
200 U/mL penicillin, and 200 ¹g/mL streptomycin. After ap-
proximately 2 months in culture, islets that clearly expanded
were removed, trypsinized, and plated onto 96-well plates to
recover ¯-cell lines. At conﬂuency, cells were usually split
at a 1:2 or 1:3 ratio. ¯TC1 cells (obtained from D. Hanahan)
used in some experiments were cultured in the same medium.
Immunocytochemistry and Histochemistry
Forinsulindetection,cellswereﬁxedin4%paraformalde-
hyde, incubated ﬁrst with guinea pig polyclonal anti-insulin
antibody and then with peroxidase-coupled goat anti–guinea
pig serum as described [14]. The peroxidase activity was
revealed using diaminobenzidine. To detect ¯-galactosidase
(¯-gal) activity, cells were ﬁxed in 0.25% glutaraldehyde
and then stained using 5-bromo-4-chloro-3-indolyl ¯-D-
galactoside (X-gal) as described [13].
Reverse Transcriptase (RT)-PCR Analysis of
Gene Expression
The primers and probes used to analyze insulin 1/insulin
2, glucagon, somatostatin, pancreatic polypeptic (PP), and
¯-actin transcripts have been speciﬁed previously [13]. The
primer sets and oligonucleotide probes used to analyze the
transcriptsforPDX-1,GK,Glut-2,andTATA-bindingprotein
(TBP) were as follows: 50-TCGCTGGGATCACTGGAGCA-
30/50-GGTCCGCTGTGT AAGCACC-30 and 50-[32P]-GACC
TTTCCCGAATGGAA CC-30 for PDX-1; 50-CACCCAACT
GCGAAATCACC-30/50-CATTTGTGGGGAGTC-50 and 50-
[32P]-GGGCCAGTGAAATCCAGGCA-30 for GK; 50-GA
GCCAAGGACCCCGTCCTA-30/50-GTGAAGACCAGGAC
CACCCC-30 and50-[32P]-GCCCTCTGCTTCCAGTACAT-30
for Glut-2; 50-AAGAGAGCCACGGACAACTG-30/50-TACT
GAACTGCTGGTGGGTC-30 and 50-[32P]-GAGTTGTGCA
GAAGTTGGGC-30 for TBP. The following PCR reactions
were used: 48±C, 45 minutes; 94±C, 2 minutes, 94±C, 30
seconds; 60±C, 1 minute, 68±C, 2 minutes for 25 cycles; 72±C
10 minutes. The PCR products were run on agarose gels,
transferred onto Hybond membranes (Amersham, Saclay,
France), and hybridized using [32P]-labeled oligonucleotide
probes. For insulin 1/insulin 2, a unique primer pair was
used for RT-PCR, and the PCR products were digested
with MspI before Southern blot analysis. Hybridization
using a single [32P]-labeled oligonucleotide probe revealed
a fragment of 71 bp for insulin 1 and another of 112 bp for
insulin 2. Quantiﬁcation of PCR products was performed
using a Phosphorimager equipped with ImageQuant software
(Molecular Dynamics) and was expressed in relation to the
internal control.
Total Cellular Insulin Content
and Insulin Secretion
Total cellular insulin content was obtained by radioim-
munoassay (RIA) kit (ICN, Irvine, CA) using acid/alcohol
extracts as described [16]. Insulin secretion assays were per-
formedwithcellsculturedin48-wellplateswhentheyreached
70% to 80% conﬂuency as described [15]. Brieﬂy, cells were
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for 2 hours in Krebs-Ringer buffer containing different glu-
cose concentrations as indicated. The secretion medium was
recovered, centrifuged for 10 minutes at 1000 rpm, and su-
pernatants were stored at ¡80±C until used for determining
insulin levels by RIA.
Determination of ¯-Gal Activity
Cells were cultured in 48-well plates in high-glucose
medium and incubated for 48 hours in the presence of GLP-1
(Sigma)and/or3-isobutyl-1-methylxanthine(IBMX)(Sigma)
at the indicated concentrations. Cells were then washed with
phosphate-buffered saline (PBS) solution and lysed in a
commercial lysis buffer (Boehringer, Mannheim, Germany).
¯-Gal activity in the protein extracts was determined by col-
orimetric assay using o-nitrophenyl ¯-D-galactopyranoxide
(ONPG) (Sigma) as substrate. Blank values obtained with
lysates from ¯TC1 cells were substracted.
RESULTS AND DISCUSSION
¯-Cell Line Derived From Ins2¡=¡ Mice
In previous studies, ¯-cell lines were isolated from islets
of transgenic mice expressing SV40 large T antigen gene un-
der the control of rat Ins1 gene promoter (Rip1-Tag2 mice)
[15, 16]. Therefore Ins2¡=¡ mice were crossed with Rip1-
Tag2 mice and an Ins2¡=¡, Rip1-Tag2 mouse line was estab-
lished. Hyperplastic islets from pancreases of Ins2¡=¡, Rip1-
Tag2 mice were isolated prior to tumor formation, i.e., at 8 to
10 weeks. After a 2-month culture in high-glucose medium
(22 mM), some islets clearly expanded as a result of efﬁ-
cient proliferation of ¯-cells transformed by SV40 T antigen,
and individually trypsinized. One of the ¯-cell lines recov-
ered from cultured cells used in this study was designated
¯Ins2¡=¡lacZ. These cells showed a doubling time of 10 days
andgrewinislets-likeclusters.Thecellswerenotfurthersub-
cloned to avoid clonal effects and used up to passage 19 in the
experiments described here.
We ﬁrst conﬁrmed that ¯Ins2¡=¡lacZ cells were ¯-cells.
¯Ins2¡=¡lacZ cells were stained using an anti-insulin antibody
(Figure 1A). Ins2¡=¡ mice carry the lacZ reporter gene un-
der control of the Ins2 promoter and the presence of ¯-gal in
¯Ins2¡=¡lacZ cellswasdetectedbyX-galstaining(Figure1B).
Because the explanted islets of origin also contained ®, ±,
andPPcells,whichproduceglucagon,somatostatin,andpan-
creatic polypeptide, respectively, we checked for the expres-
sion of the corresponding genes for these hormones by RT-
PCR, using total RNA from ¯Ins2¡=¡lacZ cells. No transcript
was found for somatostatin and pancreatic polypeptide. Few
glucagon transcripts were detected (not shown), as is fre-
FIGURE 1
Immunocytochemical detection of insulin (A) and
histochemical analysis of lacZ expression (B)i n¯Ins2¡=¡lacZ
cells. (A) Cells were ﬁxed and stained using an anti-insulin
antibody. (B) Cells were ﬁxed and ¯-gal activity was
visualized by X-gal staining. Magniﬁcation: 10£.
quentlyobservedwhenderivinga¯-celllineusingRip1-Tag2
construct [17].
We also analyzed the expression of genes encoding PDX-
1, GK, and Glut-2. PDX-1 is a transcription factor that is
essential for pancreas development and in the regulation of
islet gene expression in mature ¯-cells [18]. It was shown
that PDX-1 expression in the liver upon adenoviral vector–
mediated gene transfer in the mouse resulted in transdifferen-
tiationofasmallfractionofhepatocytesintoinsulin-secreting
cells [19]. GK is the high-KM hexokinase present in both
¯-cells as well as in hepatocytes and catalyzes the initial con-
version of glucose to glucose-6-phosphate. Finally, Glut-2 is
a glucose transporter also present in ¯-cells and hepatocytes
[20]. The role of GK and Glut-2 in glucose sensing was fully
conﬁrmed by global and tissue-speciﬁc disruption of the cor-
responding genes in the mouse. Knockout mice for GK or
Glut-2 presented defective insulin secretion and developed
diabetes [11, 12]. As presented in Figure 2, transcripts for
PDX-1, GK, and Glut-2 could be readily detected by RT-PCR
using total RNA from ¯Ins2¡=¡lacZ cells.
In conclusion, ¯Ins2¡=¡lacZ cells continue to synthesize
insulin and express important ¯-cell–speciﬁc marker genes.
Moreover, Ins2 promoter drives expression of lacZ gene in
these cells.
Glucose-Induced Insulin Secretion
From ¯Ins2¡=¡lacZ Cells
We examined the ability of ¯Ins2¡=¡lacZ cells to secrete
insulin in response to glucose because this property is fre-
quently lost when deriving a ¯-cell line [17]. We ﬁrst mea-
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FIGURE 2
RT-PCR analysis of ¯-cell–speciﬁc gene expression.
Transcripts for PDX-1 (A), Glut-2 (B), and GK (C) were
ampliﬁed using total RNA from ¯Ins2¡=¡lacZ cells and
analyzed by Southern blotting. TBP mRNA was coampliﬁed
as control. The results of 2 separate samples are presented.
The sizes of various PCR products correspond to 275 bp
(PDX-1), 150 bp (Glut-2), 162 bp (GK), and
233 bp (TBP).
of ¯Ins2¡=¡lacZ cells by RIA. The values obtained (30.04 §
2.167 mUI/106 cells) were comparable to those previously
reported with other murine ¯-cell lines in which both the
Ins1 and Ins2 genes were functional [15, 16]. Thus, increased
Ins1 gene expression appears to quantitatively compensate
the absence of insulin transcripts from Ins2-null alleles in
¯Ins2¡=¡lacZ cells. Glucose-induced insulin secretion from
¯Ins2¡=¡lacZ cells was subsequently analyzed by incubating
the cells in Krebs-Ringer secretion buffer supplemented with
2.8, 8.3, or 16.7 mM glucose. After incubation for 2 hours,
the amount of insulin released in the medium was determined
by RIA and the results obtained are presented in Figure 3.
Insulinreleasefrom¯Ins2¡=¡lacZ cellsincreasedwithincreas-
ing glucose concentrations. The values obtained at 16.7 mM
glucose were about 5-fold higher as compared to those at
2.8 mM glucose. Insulin secretion from ¯Ins2¡=¡lacZ cells
was also examined in the presence of IBMX, which is known
to potentiate glucose-stimulated insulin release from ¯-cells.
Addition of 0.5 mM IBMX in the secretion buffer enhanced
insulin release from ¯Ins2¡=¡lacZ cells at all glucose concen-
FIGURE 3
Glucose-induced insulin secretion in ¯Ins2¡=¡lacZ cells.
Insulin release was measured in the absence or in the
presence of 0.5 mM IBMX. The incubation time was 2
hours. Values are means § SE from triplicate assays.
trations(Figure3).InthepresenceofIBMX,insulinsecretion
athighglucoseconcentration(16.7mM)was»8.3-foldhigher
than that at low glucose concentration (2.8 mM). All these re-
sults indicate that ¯Ins2¡=¡lacZ cells have retained glucose
responsiveness for insulin secretion.
Ins1 Gene is Up-Regulated in ¯Ins2¡=¡lacZ
Cells
Toinvestigatepossibleup-regulationoftheIns1geneinthe
absenceofIns2transcriptsin¯Ins2¡=¡lacZ cells,wecompared
insulintranscriptsproducedin¯Ins2¡=¡lacZ cellswiththosein
¯TC1 cells. This latter cell line was derived from Rip1-Tag2
mice in which both the Ins1 and Ins2 genes are functional.
Insulin gene expression was analyzed by RT-PCR using total
cellularRNA.In¯TC1cells,Ins1transcriptsrepresentthemi-
norityofinsulintranscripts(Figure4B).In¯Ins2¡=¡lacZ cells,
the amounts of Ins1 transcripts were signiﬁcantly higher than
those found in ¯TC1 cells (Figure 4A). Quantitative analysis
of RT-PCR products for insulin as well as ¯-actin transcripts
showed that Ins1 transcripts in ¯Ins2¡=¡lacZ cells represent
55% to 88% of total insulin transcripts present in ¯TC1 cells.
These results indicate that the Ins1 gene is up-regulated in
¯Ins2¡=¡lacZ cells to compensate for the absence of Ins2 tran-
scripts. It can be inferred from this study that Ins1 gene up-
regulation could also potentially take place in individual ¯-
cells in vivo in Ins2¡=¡ mice, in the compensating responses
exhibited by these mutants to maintain normal glucose home-
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FIGURE 4
RT-PCR analysis of insulin gene expression in ¯Ins2¡=¡lacZ
(A) and ¯TC1 (B) cells. Transcripts for Insulin 1
(Ins1)/Insulin 2 (Ins2) were ampliﬁed using total RNA from
¯Ins2¡=¡lacZ or ¯TC1 cells and analyzed by Southern
blotting. ¯-Actin mRNA was coampliﬁed as control. The
results of 2 separate samples are presented. The sizes of
various PCR products correspond to 76 bp (Insulin 1), 112
bp (Insulin 2), and 243 bp (¯-actin).
Induction of the Ins2-lacZ Gene
in ¯Ins2¡=¡lacZ Cells
Regulation of insulin gene expression has been examined
in many studies using different ¯-cell lines transfected with
reporter genes under control of rodent or human insulin pro-
moter. In some of these studies, several-fold induction of in-
sulin promoter activity by glucose was reported [21, 22]. Be-
cause ¯Ins2¡=¡lacZ cells express the lacZ gene inserted at the
Ins2 locus, these cells represent an interesting tool for testing
or screening of molecules that can up-regulate Ins2 promoter
activity, because lacZ expression can be easily monitored by
measuring¯-galactivityincellularextracts.Wecouldnotex-
amine the effect of glucose on Ins2-lacZ expression, because
only a moderate decrease, if any, of ¯-gal activity was ob-
served when ¯Ins2¡=¡lacZ cells grown in high glucose were
transferred to low-glucose medium (not shown). We could,
however, test the effect of GLP-1 and IBMX on Ins2-lacZ
gene expression in ¯Ins2¡=¡lacZ cells. GLP-1 is a hormone
secreted by the gut during digestion and has been shown to
stimulateinsulingenetranscriptionunderhyperglycemiccon-
ditions[23].IBMXhasalsobeenreportedtostimulateinsulin
gene expression [24].
As shown in Figure 5, incubation of ¯Ins2¡=¡lacZ cells
cultured in high-glucose medium with 10¡7 M GLP-1 for
2 days resulted in 97% increase in ¯-gal activity as compared
to ¯Ins2¡=¡lacZ cells cultured without GLP-1. A similar in-
crease in ¯-gal activity was also observed for ¯Ins2¡=¡lacZ
cells incubated with 0.5 mM IBMX. The ¯-gal activity in
¯Ins2¡=¡lacZ cells cultured in the presence of both GLP-1 and
IBMX was increased up to 157% as compared to untreated
FIGURE 5
Analysis of ¯-gal activity in ¯Ins2¡=¡lacZ cells cultured
under various conditions. ¯-Gal activity was determined in
¯Ins2¡=¡lacZ cells cultured in high-glucose medium (22
mM) supplemented or not for 48 hours with 10¡7 M GLP-1
and/or 0.5 mM IBMX. A blank value obtained with ¯TC1
cells was substracted. Values are means § SE from triplicate
and quadruplicate assays.
cells. These results demonstrate that the Ins2 promoter can be
induced in ¯Ins2¡=¡lacZ cells.
In conclusion, the advantage of such a model ¯Ins2¡=¡lacZ
cell line is twofold: (1) to understand the transcriptional net-
work governing the expression of the Ins2 promoter, and
(2) to study the mechanisms involved in the up-regulation
of Ins1 promoter activity. These cells also represent an in-
teresting new tool for the screening of molecules that could
stimulate Ins2 promoter activity under high-glucose condi-
tions, and therefore would have potential therapeutic interest
for type 2 diabetes, because the Ins2 gene in the mouse is
homologous to the human insulin gene.
REFERENCES
[1] Kahn, B. B. (1998) Type 2 diabetes: When insulin secretion
fails to compensate for insulin resistance. Cell, 92, 593–596.
[2] Docherty, K., and Clark, A. R. (1994) Nutrient regulation of
insulin gene expression. FASEB J., 8, 20–27.
[3] Dumonteil, E., and Philippe, J. (1996) Insulin gene: Organisa-
tion, expression and regulation. Diabetes Metab., 22, 164–173.
[4] Nieuwenhuizen, A. G., Schuiling, G. A., Moes, H., and Koiter,
T.R.(1997)Roleofincreasedinsulindemandintheadaptation
of the endocrine pancreas to pregnancy. Acta Physiol. Scand.,
159, 303–312.12 L. LEROUX ET AL.
[5] Bernard, C., Thibault, C., Berthault, M. F., Magnan, C.,
Saulnier, C., Portha, B., Pralong, W. F., Penicaud, L., and
Ktorza, A. (1998) Pancreatic beta-cell regeneration after 48-
h glucose infusion in mildly diabetic rats is not correlated with
functional improvement. Diabetes, 47, 1058–1065.
[6] Bonner, W. S., Deery, D., Leahy, J. L., and Weir, G. C. (1989)
Compensatorygrowthofpancreaticbeta-cellsinadultratsafter
short-term glucose infusion. Diabetes, 38, 49–53.
[7] Araki,E.,Lipes,M.A.,Patti,M.E.,Bruning,J.C.,Haag,B.R.,
Johnson, R. S., and Kahn, C. R. (1994) Alternative pathway of
insulin signalling in mice with targeted disruption of the IRS-1
gene. Nature, 372, 186–190.
[8] Withers, D. J., Gutierrez, J. S., Towery, H., Burks, D. J., Ren,
J.M.,Previs,S.,Zhang,Y.,Bernal,D.,Pons,S.,Shulman,G.I.,
Bonner, Weir, S., and White, M. F. (1998) Disruption of IRS-2
causes type 2 diabetes in mice. Nature, 391, 900–904.
[9] Jonsson, J., Carlsson, L., Edlund, T., and Edlund, H. (1994)
Insulin-promoter-factor1isrequiredforpancreasdevelopment
in mice. Nature, 371, 606–609.
[10] Marshak,S.,Ben-Shushan,E.,Shoshkes,M.,Havin,L.,Cerasi,
E., and Melloul, D. (2001) Regulatory elements involved
in human pdx-1 gene expression. Diabetes, 50(Suppl 1), S37–
S38.
[11] Bali, D., Svetlanov, A., Lee, H. W., Fusco-DeMane, D., Leiser,
M., Li, B., Barzilai, N., Surana, M., Hou, H., and Fleischer, N.
(1995) Animal model for maturity-onset diabetes of the young
generatedbydisruptionofthemouseglucokinasegene.J.Biol.
Chem., 270, 21464–21467.
[12] Guillam,M.T.,Hummler,E.,Schaerer,E.,Yeh,J.I.,Birnbaum,
M. J., Beermann, F., Schmidt, A., Deriaz, N., Thorens, B., and
Wu,J.Y.(1997)Earlydiabetesandabnormalpostnatalpancre-
atic islet development in mice lacking Glut-2. Nat. Genet., 17,
327–330.
[13] Leroux, L., Desbois, P., Lamotte, L., Duvilli´ e, B., Cordonnier,
N.,Jackerott,M.,Jami,J.,Bucchini,D.,andJoshi,R.L.(2001)
Compensatory responses in mice carrying a null mutation for
Ins1 or Ins2. Diabetes, 50(Suppl 1), S150–S153.
[14] Duvilli´ e,B.,Cordonnier,N.,Deltour,L.,Dandoy,DronF.,Itier,
J. M., Monthioux, E., Jami, J., Joshi, R. L., and Bucchini, D.
(1997) Phenotypic alterations in insulin-deﬁcient mutant mice.
Proc. Natl. Acad. Sci. U.S.A., 94, 5137–5140.
[15] Efrat, S., Leiser, M., Surana, M., Tal, M., Fusco-Demane, D.,
and Fleischer, N. (1993) Murine insulinoma cell line with nor-
mal glucose-regulated insulin secretion. Diabetes, 42, 901–
907.
[16] Radvanyi, F., Christgau, S., Baekkeskov, S., Jolicoeur, C.
and Hanahan, D. (1993) Pancreatic beta cells cultured from
individual preneoplastic foci in a multistage tumorigenesis
pathway: A potentially general technique for isolating phys-
iologically representative cell lines. Mol. Cell. Biol., 13, 4223–
4232.
[17] Levine,F.(1997)Genetherapyfordiabetes:Strategiesforbeta-
cell modiﬁcation and replacement. Diabetes Metab. Rev., 13,
209–246.
[18] Yamaoka,T.,andItakura,M.(1999)Developmentofpancreatic
islets. Int. J. Mol. Med., 3, 247–261.
[19] Ferber, S., Halkin, A., Cohen, H., Ber, I., Einav, Y., Goldberg,
I., Barshack, I., Seijffers, R., Kopolovic, J., Kaiser, N., and
Karasik, A. (2000) Pancreatic and duodenal homeobox gene
1 induces expression of insulin genes in liver and amelio-
ratesstreptozotocin-inducedhyperglycemia.Nat.Med.,6,568–
572.
[20] Rolland, F., Winderickx, J., and Thevelein, J. M. (2001)
Glucose-sensing mechanisms in eukaryotic cells. Trends
Biochem. Sci., 26, 310–317.
[21] deVargas,L.,Sobolewski,J.,Siegel,R.,andMoss,L.G.(1997)
Individualbetacellswithintheintactisletdifferentiallyrespond
to glucose. J. Biol. Chem., 272, 26573–26577.
[22] Leibiger,B.,Moede,T.,Schwarz,T.,Brown,G.R.,Kohler,M.,
Leibiger,I.B.,andBerggren,P.O.(1998)Short-termregulation
of insulin gene transcription by glucose. Proc. Natl. Acad. Sci.
U.S.A., 95, 9307–9312.
[23] Drucker, D. J. (1998) Glucagon-like peptides. Diabetes, 47,
159–169.
[24] Kohnert,K.D.,Ziegler,B.,HahnvonDorsche,H.,Hehmke,B.,
andSchroder,D.(1982)Effectsof3-isobutyl-1-methylxanthine
on neonatal pancreatic islets maintained in tissue culture. Mol.
Cell. Endocrinol., 28, 425–437.